Navigation Links
BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
Date:8/17/2010

jects twelve to 17 years of age and the Adult ADHD Self-Report Scale (ASRS) in subjects ages 18 and above.  The Clinical Global Impression of Improvement (CGI-I) scale will be assessed to determine improvement in global impression of behavior, symptoms and functioning relative to treatment as the primary efficacy endpoint for global function.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations about the timing, conduct and impact of the clinical trial
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Kinex Pharmaceuticals announced the receipt ... Company,s KX2-391 Ointment for the commencement of a Phase ... Company,s third IND to be allowed by the US ... is a synthetic, orally active and highly selective inhibitor ... promotes the induction of p53, G2/M arrest of proliferating ...
(Date:7/24/2014)...  The American Association for Homecare (AAHomecare) yesterday ... help address audit issues in the HME industry ... the information technology lead in shaping its HME ... billing and business management solutions for nearly 3,000 ... support this important initiative on behalf of all ...
(Date:7/24/2014)... Research and Markets  has announced the ... Product, Component, Application and Geography - Global Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 ... a moderate growth as the markets of the U.S. ... the saturation levels. The demand is expected to come ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
... Mettler-Toledo International Inc. (NYSE: MTD ) today ... Life Sciences Conference in New York on Wednesday, September 22, ... webcast of the presentation, visit the investor relations page on ... of the webcast will be available for seven days. ...
... HeartWare International, Inc. (Nasdaq: HTWR ; ... circulatory support technologies that are revolutionizing the treatment of ... is scheduled to make an investor presentation at the ... 21, at 12:30 pm EDT.  The conference will be ...
Cached Medicine Technology:HeartWare to Present at the UBS 2010 Global Life Sciences Conference 2
(Date:7/25/2014)... July 25, 2014 Splashtop, Inc. announced ... Program . Splashtop Business and Splashtop Enterprise will now ... will leverage the MaaS360 WorkPlace SDK to enable enterprise-grade ... Business and Splashtop Enterprise offer secure remote access, support, ... High performance, ease of use, collaborative features, and ...
(Date:7/25/2014)... 2014 Training Mask LLC, is proud ... an endorsement agreement to promote the mask and its’ ... for over 10 years, and ran over 30 ultra ... of the Angeles Crest 100-mile endurance run. Brian is ... of the endurance, strength and conditioning paradigm. He created ...
(Date:7/25/2014)... An alpha olefin is an olefin or an ... alpha position of the carbon chain, or between the 1st ... namely, branched and linear (or normal). The alpha olefin market ... its applications such as polyethylene co-monomers and synthetic lubricants, across ... Europe have been lucrative markets for alpha olefins; however, Asia-Pacific ...
(Date:7/25/2014)... -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) ... Patent Pool (MPP) and Gilead Sciences, Inc. to ... promising new HIV medication. The agreement was announced ... in Melbourne, Australia. , While TAF is ... suggests it could be a key ingredient in ...
(Date:7/25/2014)... 2014 Ross A. Clevens, MD, FACS, ... to join the exclusive Obagi Clinical Advisory Board, comprised ... surgeons, plastic surgeons and dermatologists. , Dr. Clevens ... Board of thought leaders held its first meeting in ... to give Obagi the opportunity to meet with eight ...
Breaking Medicine News(10 mins):Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4Health News:Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie 2Health News:Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie 3Health News:Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2
... Fitzpatrick, PhD, RN, Executive Vice President and Healthcare Practice ... winning poster Optimizing Nursing Human Capital: The Five Rights ... (AONE) 42nd Annual Meeting and Exposition, held April 15 ... in San Antonio Texas. The AONE Annual Meeting and ...
... N.J.¿ April 8 ORTHOCON¿ Inc. today announced that ... President and Chief Executive Officer. The company also announced ... led by top-tier healthcare investors. ORTHOCON is developing ... Company,s versatile technology platform may be leveraged to deliver ...
... Solutions and Logicalis Initiate Collaborative Sales Agreements ... Access to Federal Healthcare IT Stimulus FundsCHICAGO, ... interoperability of disparate healthcare IT systems, announced ... Software Information Systems (SIS) and Micro Solutions. ...
... to its line of Workmaster® Storage Cabinets (WSC). , ... ... adds 7 new pedestal configurations to its line of ... large capacity drawers in combination with split-door cabinet compartments. The cabinet ...
... received full accreditation from URAC as a health call center. By ... all relevant standards and performs nurse line and other health information ... appropriate care and treatment advice. , ... South Portland, ...
... Seguro Popular, a Mexican health care program instituted in ... poorer households, according to an evaluation conducted by researchers ... , The study was designed and led by ... of the Institute for Quantitative Social Science at Harvard. ...
Cached Medicine News:Health News:Dr. Therese Fitzpatrick to Present Award Winning Poster at AONE 2Health News:ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing 2Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 2Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 3Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 4Health News:Even MORE Storage for IAC Industries' Workmaster™ Storage Cabinet Workbenches 2Health News:Even MORE Storage for IAC Industries' Workmaster™ Storage Cabinet Workbenches 3Health News:SironaHealth Receives URAC Accreditation as a Health Call Center 2Health News:SironaHealth Receives URAC Accreditation as a Health Call Center 3Health News:New Mexican health-care program successful at reducing crippling health care costs 2Health News:New Mexican health-care program successful at reducing crippling health care costs 3
Dust covers for a variety of Zeiss microscopes...
Inquire...
... An economical laboratory tissue culture microscope, ... to expand their applications. Olympus has taken ... the CKX41. Fluorescence can be used with ... images can be carried out on the ...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
Medicine Products: